Saturday, March 25, 2023 | Back issues
Courthouse News Service Courthouse News Service

Steven Sklar v. Amarin Corp. PLC; Joseph Zakrzewski

Amarin misrepresented the Food and Drug Administration's intent to approve its product, Vascepa, and the CEO dumped $11 million of his own shares at the inflated prices, a class claims.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.